Excalibur Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.22M | Sell |
51,737
-1,337
| -3% | -$154K | 2.23% | 7 |
|
|
2025
Q4 | $5.59M | Buy |
53,074
+1,076
| +2% | +$101K | 2.01% | 8 |
|
|
2025
Q3 | $4.36M | Buy |
51,998
+139
| +0.3% | +$11.4K | 1.58% | 10 |
|
|
2025
Q2 | $4.11M | Buy |
51,859
+1,432
| +3% | +$114K | 1.54% | 12 |
|
|
2025
Q1 | $4.53M | Buy |
50,427
+385
| +0.8% | +$35.9K | 1.78% | 10 |
|
|
2024
Q4 | $4.98M | Buy |
50,042
+1,904
| +4% | +$196K | 1.98% | 8 |
|
|
2024
Q3 | $5.47M | Sell |
48,138
-436
| -0.9% | -$51.8K | 2.08% | 7 |
|
|
2024
Q2 | $6.01M | Buy |
48,574
+387
| +0.8% | +$49.9K | 2.45% | 6 |
|
|
2024
Q1 | $6.36M | Sell |
48,187
-217
| -0.4% | -$26.7K | 2.69% | 6 |
|
|
2023
Q4 | $5.29M | Sell |
48,404
-23
| -0% | -$2.39K | 2.48% | 7 |
|
|
2023
Q3 | $4.99M | Buy |
48,427
+763
| +2% | +$82.2K | 2.59% | 8 |
|
|
2023
Q2 | $5.5M | Sell |
47,664
-2,204
| -4% | -$250K | 2.8% | 7 |
|
|
2023
Q1 | $5.31M | Sell |
49,868
-315
| -0.6% | -$34K | 2.75% | 7 |
|
|
2022
Q4 | $5.57M | Sell |
50,183
-1,976
| -4% | -$202K | 2.91% | 7 |
|
|
2022
Q3 | $4.49M | Sell |
52,159
-4,267
| -8% | -$381K | 2.51% | 7 |
|
|
2022
Q2 | $5.14M | Sell |
56,426
-9,474
| -14% | -$840K | 2.68% | 8 |
|
|
2022
Q1 | $5.41M | Buy |
65,900
+1,803
| +3% | +$142K | 2.34% | 8 |
|
|
2021
Q4 | $4.91M | Buy |
64,097
+305
| +0.5% | +$24.3K | 1.98% | 13 |
|
|
2021
Q3 | $4.79M | Sell |
63,792
-104
| -0.2% | -$7.91K | 2.1% | 12 |
|
|
2021
Q2 | $4.97M | Buy |
63,896
+731
| +1% | +$54.4K | 2.25% | 12 |
|
|
2021
Q1 | $4.65M | Buy |
63,165
+3,133
| +5% | +$231K | 2.29% | 11 |
|
|
2020
Q4 | $4.69M | Buy |
60,032
+349
| +0.6% | +$26.7K | 2.52% | 11 |
|
|
2020
Q3 | $4.72M | Sell |
59,683
-958
| -2% | -$75K | 2.86% | 9 |
|
|
2020
Q2 | $4.47M | Sell |
60,641
-1,576
| -3% | -$119K | 2.98% | 9 |
|
|
2020
Q1 | $4.57M | Buy |
62,217
+506
| +0.8% | +$39.8K | 3.53% | 9 |
|
|
2019
Q4 | $5.36M | Sell |
61,711
-19
| -0% | -$1.56K | 3.5% | 9 |
|
|
2019
Q3 | $4.96M | Sell |
61,730
-524
| -0.8% | -$42K | 4.45% | 6 |
|
|
2019
Q2 | $4.98M | Sell |
62,254
-2,989
| -5% | -$229K | 4.59% | 7 |
|
|
2019
Q1 | $5.18M | Sell |
65,243
-2,221
| -3% | -$166K | 4.88% | 6 |
|
|
2018
Q4 | $4.92M | Sell |
67,464
-8,513
| -11% | -$601K | 4.97% | 7 |
|
|
2018
Q3 | $5.14M | Sell |
75,977
-15,091
| -17% | -$961K | 4.39% | 7 |
|
|
2018
Q2 | $5.28M | Sell |
91,068
-2,666
| -3% | -$150K | 4.2% | 6 |
|
|
2018
Q1 | $4.87M | Buy |
93,734
+6,684
| +8% | +$361K | 3.96% | 8 |
|
|
2017
Q4 | $4.67M | Buy |
87,050
+2,268
| +3% | +$126K | 3.93% | 8 |
|
|
2017
Q3 | $5.18M | Sell |
84,782
-6,859
| -7% | -$416K | 4.4% | 6 |
|
|
2017
Q2 | $5.6M | Sell |
91,641
-923
| -1% | -$56.2K | 5.02% | 6 |
|
|
2017
Q1 | $5.61M | Sell |
92,564
-786
| -0.8% | -$47.7K | 5% | 6 |
|
|
2016
Q4 | $5.24M | Buy |
93,350
+2,702
| +3% | +$158K | 4.78% | 7 |
|
|
2016
Q3 | $5.4M | Sell |
90,648
-5,575
| -6% | -$326K | 5.12% | 7 |
|
|
2016
Q2 | $5.29M | Sell |
96,223
-356
| -0.4% | -$18.9K | 4.55% | 7 |
|
|
2016
Q1 | $4.88M | Sell |
96,579
-147
| -0.2% | -$7.2K | 4.37% | 7 |
|
|
2015
Q4 | $4.88M | Sell |
96,726
-1,588
| -2% | -$80.1K | 4.53% | 7 |
|
|
2015
Q3 | $4.63M | Buy |
98,314
+2,025
| +2% | +$108K | 4.63% | 7 |
|
|
2015
Q2 | $5.23M | Buy |
96,289
+47
| +0% | +$2.64K | 4.89% | 7 |
|
|
2015
Q1 | $5.28M | Sell |
96,242
-2,319
| -2% | -$131K | 5.11% | 7 |
|
|
2014
Q4 | $5.34M | Sell |
98,561
-330
| -0.3% | -$18.4K | 5.38% | 7 |
|
|
2014
Q3 | $5.59M | Sell |
98,891
-289
| -0.3% | -$16.2K | 5.75% | 6 |
|
|
2014
Q2 | $5.47M | Sell |
99,180
-1,572
| -2% | -$85.8K | 5.71% | 6 |
|
|
2014
Q1 | $5.46M | Sell |
100,752
-5,868
| -6% | -$304K | 5.98% | 6 |
|
|
2013
Q4 | $5.09M | Sell |
106,620
-944
| -0.9% | -$43.2K | 5.55% | 7 |
|
|
2013
Q3 | $4.89M | Buy |
107,564
+289
| +0.3% | +$13.2K | 5.74% | 6 |
|
|
2013
Q2 | $4.75M | Buy |
+107,275
| New | +$4.79M | 5.9% | 6 |
|
Other funds holding MRK
VCM
VPM
Excalibur Management's MRK Position: Q1 2026 in Review
Excalibur Management reduced its Merck (MRK) stake by 2.5% in Q1 2026, selling an estimated $154K and leaving 51,737 shares worth $6.22M. The position accounts for 2.23% of the portfolio, ranked #7.
Excalibur Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.36M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Excalibur Management held 51,737 shares of Merck worth $6.22M as of Q1 2026.
- Excalibur Management sold 1,337 Merck shares in Q1 2026, an estimated $154K.
- Merck made up 2.23% of Excalibur Management's portfolio in Q1 2026, its #7 holding.
- Excalibur Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Excalibur Management's Merck position peaked at $6.36M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.